• Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment–Related Problems on Reductions in Productivity from a Managerial Perspective

    Sep 1, 2017, 00:00

  • Making Real-World Evidence More Useful for Decision Making

    Sep 1, 2017, 00:00

  • Evaluation of a Stratified National Breast Screening Program in the United Kingdom- An Early Model-Based Cost-Effectiveness Analysis

    Sep 1, 2017, 00:00

  • Market Exclusivity Time for Top Selling Originator Drugs in Canada- A Cohort Study

    Sep 1, 2017, 00:00

  • Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness- Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

    Sep 1, 2017, 00:00

  • ERRATUM

    Sep 1, 2017, 00:00

  • Editorial Board

    Sep 1, 2017, 00:00

  • A Systematic Review of the Economic Evidence for Home Support Interventions in Dementia

    Sep 1, 2017, 00:00

  • Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Sep 1, 2017, 00:00

  • Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

    Sep 1, 2017, 00:00

  • Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb- Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates

    Sep 1, 2017, 00:00

  • An Experience-Based Value Set for the EQ-5D-5L in Germany

    Sep 1, 2017, 00:00

  • Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists

    Sep 1, 2017, 00:00

  • Copyright/Subscription

    Sep 1, 2017, 00:00

  • Cost-Utility of Partially Implantable Active Middle Ear Implants for Sensorineural Hearing Loss- A Decision Analysis

    Sep 1, 2017, 00:00

  • Table of Contents

    Sep 1, 2017, 00:00

  • Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis

    Sep 1, 2017, 00:00

  • A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

    Sep 1, 2017, 00:00

  • Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration

    Sep 1, 2017, 00:00

  • The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria

    Sep 1, 2017, 00:00

  • Discordance in Utility Measurement in Persons with Neurological Conditions- A Comparison of the SF-6D and the HUI3

    Sep 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure

    Sep 1, 2017, 00:00

  • Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier- A 15-Year Nationwide Study

    Sep 1, 2017, 00:00

  • Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia

    Sep 1, 2017, 00:00

  • A Systematic Review of the Techniques Used to Value Temporary Health States

    Sep 1, 2017, 00:00

  • Economic Evaluations of Pathology Tests, 2010-2015- A Scoping Review

    Sep 1, 2017, 00:00

  • Value-Based Payments and Incentives to Improve Care- A Case Study of Patients with Type 2 Diabetes in Medicare Advantage

    Sep 1, 2017, 00:00

  • Do Robotic Surgical Systems Improve Profit Margins? A Cross-Sectional Analysis of California Hospitals

    Sep 1, 2017, 00:00

  • Scale Linking to Enable Patient-Reported Outcome Performance Measures Assessed with Different Patient-Reported Outcome Measures

    Sep 1, 2017, 00:00

  • Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries

    Sep 1, 2017, 00:00

  • Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection

    Sep 1, 2017, 00:00

  • Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L

    Jul 1, 2017, 00:00

  • Dealing with Uncertainty and Accounting for Social Value Judgments in Assessments of Orphan Drugs- Evidence from Four European Countries

    Jul 1, 2017, 00:00

  • Less Is More- Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

    Jul 1, 2017, 00:00

  • Copyright/Subscription

    Jul 1, 2017, 00:00

  • The HIQA’s Health Technology Assessment of Breast Screening- Highlighting Some of the Challenges Posed by Evaluations of Screening Programs

    Jul 1, 2017, 00:00

  • Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia- An Indirect Treatment Comparison

    Jul 1, 2017, 00:00

  • Valid Outcome Measures in Care for Older People- Comparing the ASCOT and the ICECAP-O

    Jul 1, 2017, 00:00

  • Cost-Effectiveness Analysis of an Automated Medication System Implemented in a Danish Hospital Setting

    Jul 1, 2017, 00:00

  • Pharmaceutical Pricing in Germany- How Is Value Determined within the Scope of AMNOG?

    Jul 1, 2017, 00:00

  • Remembering a Giant in Economics- Kenneth J. Arrow (1922–2017)

    Jul 1, 2017, 00:00

  • A Review of Empirical Analyses of Disinvestment Initiatives

    Jul 1, 2017, 00:00

  • Impact of Survey Administration Mode on the Results of a Health-Related Discrete Choice Experiment- Online and Paper Comparison

    Jul 1, 2017, 00:00

  • Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Trials

    Jul 1, 2017, 00:00

  • The Prime Diabetes Model- Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus

    Jul 1, 2017, 00:00

  • Testing the External Validity of a Discrete Choice Experiment Method- An Application to Latent Tuberculosis Infection Treatment

    Jul 1, 2017, 00:00

  • Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?

    Jul 1, 2017, 00:00

  • Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials- Empirical Evidence for the ASCO Value Framework

    Jul 1, 2017, 00:00

  • Table of Contents

    Jul 1, 2017, 00:00

  • What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews

    Jul 1, 2017, 00:00

  • Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials- An ISPOR COA Emerging Good Practices Task Force Report

    Jul 1, 2017, 00:00

  • In this Issue

    Jul 1, 2017, 00:00

  • Public Preferences for Lung Cancer Screening Policies

    Jul 1, 2017, 00:00

  • How to Compare the Length of Stay of Two Samples of Inpatients? A Simulation Study to Compare Type I and Type II Errors of 12 Statistical Tests

    Jul 1, 2017, 00:00

  • Ethics of Informed Consent for Pragmatic Trials with New Interventions

    Jul 1, 2017, 00:00

  • Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands

    Jun 1, 2017, 00:00

  • Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION)- A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population

    Jun 1, 2017, 00:00

  • Value for Money in H1N1 Influenza- A Systematic Review of the Cost-Effectiveness of Pandemic Interventions

    Jun 1, 2017, 00:00

  • Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations

    Jun 1, 2017, 00:00

  • Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions- A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient C ...

    Jun 1, 2017, 00:00

  • Mind the Gap- Hospitalizations from Multiple Sources in a Longitudinal Study

    Jun 1, 2017, 00:00

  • Economic Impacts of the Generic Drug User Fee Act Fee Structure

    Jun 1, 2017, 00:00

  • Challenges of Developing an Observable Parent-Reported Measure- A Qualitative Study of Functional Impact of ADHD in Children

    Jun 1, 2017, 00:00

  • Ulcerative Colitis Treatment Patterns and Cost of Care

    Jun 1, 2017, 00:00

  • The Role of Patient-Reported Outcome Measures in Value-Based Payment Reform

    Jun 1, 2017, 00:00

  • Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

    Jun 1, 2017, 00:00

  • The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs

    Jun 1, 2017, 00:00

  • Editorial Board

    Jun 1, 2017, 00:00

  • The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process

    Jun 1, 2017, 00:00

  • In this Issue

    Jun 1, 2017, 00:00

  • Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling

    Jun 1, 2017, 00:00

  • Message from Co-Editors

    May 1, 2017, 00:00

  • Editorial Board

    May 1, 2017, 00:00

  • 22nd International Abstracts Book

    May 1, 2017, 00:00

  • ToC

    May 1, 2017, 00:00

  • Copyright/Subscription

    May 1, 2017, 00:00

  • 22ND International Abstracts-FDS

    May 1, 2017, 00:00

  • Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Thresholds in Global Health- Taking a Multisectoral Perspective

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System

    Apr 1, 2017, 00:00

  • Eliciting Preferences for Information Provision in Newborn Bloodspot Screening Programs

    Apr 1, 2017, 00:00

  • Be Careful What You Ask For- Effects of Benefit Descriptions on Diabetes Patients’ Benefit-Risk Tradeoff Preferences

    Apr 1, 2017, 00:00

  • Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission- An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial

    Apr 1, 2017, 00:00

  • A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models

    Apr 1, 2017, 00:00

  • In this Issue

    Apr 1, 2017, 00:00

  • Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical Routine

    Apr 1, 2017, 00:00

  • Table of Contents

    Apr 1, 2017, 00:00

  • Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy- EQ-5D-3L and NEWQOL-6D

    Apr 1, 2017, 00:00

  • A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years

    Apr 1, 2017, 00:00

  • A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults- Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development

    Apr 1, 2017, 00:00

  • Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

    Apr 1, 2017, 00:00

  • The PMA Scale- A Measure of Physicians’ Motivation to Adopt Medical Devices

    Apr 1, 2017, 00:00

  • Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials- Foundational Qualitative Research

    Apr 1, 2017, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment (HTA)- A Comparative Study of Six HTA Agencies

    Apr 1, 2017, 00:00

  • Editorial Board

    Apr 1, 2017, 00:00

  • Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models- Stop Developing, Start Evaluating

    Apr 1, 2017, 00:00

  • Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

    Apr 1, 2017, 00:00

  • The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule- Economic Evaluation

    Apr 1, 2017, 00:00

  • Copyright/Subscription

    Apr 1, 2017, 00:00

  • Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States

    Apr 1, 2017, 00:00

  • Estimating an EQ-5D-5L Value Set for China

    Apr 1, 2017, 00:00

  • Balancing the Optimal and the Feasible- A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences

    Apr 1, 2017, 00:00

  • A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer

    Apr 1, 2017, 00:00

  • Accounting for Cured Patients in Cost-Effectiveness Analysis

    Apr 1, 2017, 00:00

  • Determining Criteria and Weights for Prioritizing Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Apr 1, 2017, 00:00

  • Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents

    Mar 1, 2017, 00:00

  • Time to Review the Role of Surrogate End Points in Health Policy- State of the Art and the Way Forward

    Mar 1, 2017, 00:00

  • Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer

    Mar 1, 2017, 00:00

  • Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus- Informing Economic Modeling

    Mar 1, 2017, 00:00

  • Emerging Guidelines for Patient Engagement in Research

    Mar 1, 2017, 00:00

  • Joint Utility Estimators in Substance Use Disorders

    Mar 1, 2017, 00:00

  • Constrained Optimization Methods in Health Services Research—An Introduction- Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Mar 1, 2017, 00:00

  • ERRATUM

    Mar 1, 2017, 00:00

  • External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD)- Report of the Third COPD Modeling Meeting

    Mar 1, 2017, 00:00

  • Editorial Board

    Mar 1, 2017, 00:00

  • Health State Utilities Associated with Glucose Monitoring Devices

    Mar 1, 2017, 00:00

  • Copyright/Subscription

    Mar 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly

    Mar 1, 2017, 00:00

  • Table of Contents

    Mar 1, 2017, 00:00

  • Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD

    Mar 1, 2017, 00:00

  • Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis- A Population-Based Study in Ontario, Canada

    Mar 1, 2017, 00:00

  • Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Mar 1, 2017, 00:00

  • Quality Control Process for EQ-5D-5L Valuation Studies

    Mar 1, 2017, 00:00

  • Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma- A Cost-Effectiveness Analysis

    Mar 1, 2017, 00:00

  • The Impact of China’s National Essential Medicine Policy and Its Implications for Urban Outpatients- A Multivariate Difference-in-Differences Study

    Mar 1, 2017, 00:00

  • The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction- Results from the KORINNA Follow-Up Study

    Mar 1, 2017, 00:00

  • A Review of Patient-Reported Outcome Labeling in the United States (2011–2015)

    Mar 1, 2017, 00:00

  • Health Technology Assessment (HTA) Case Studies- Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland

    Mar 1, 2017, 00:00

  • Preference Weighting of Health State Values- What Difference Does It Make, and Why?

    Mar 1, 2017, 00:00

  • The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation- A Systematic Review

    Mar 1, 2017, 00:00

  • In this Issue

    Mar 1, 2017, 00:00

  • Treacle and Smallpox- Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment

    Mar 1, 2017, 00:00

  • An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands

    Mar 1, 2017, 00:00

  • Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

    Mar 1, 2017, 00:00

  • Advancing High-Quality Value Assessments of Health Care Interventions

    Feb 1, 2017, 00:00

  • Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks

    Feb 1, 2017, 00:00

  • Comparing Increments in Utility of Health- An Individual-based Approach

    Feb 1, 2017, 00:00

  • Cost-Effectiveness and Dynamic Efficiency- Does the Solution Lie Within?

    Feb 1, 2017, 00:00

  • The HTA Core Model—10 Years of Developing an International Framework to Share Multidimensional Value Assessment

    Feb 1, 2017, 00:00

  • Value to Whom? The Patient Voice in the Value Discussion

    Feb 1, 2017, 00:00

  • Value Assessment in the Regulatory Context

    Feb 1, 2017, 00:00

  • Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

    Feb 1, 2017, 00:00

  • Toward a Hedonic Value Framework in Health Care

    Feb 1, 2017, 00:00

  • Concerns Around Budget Impact Thresholds- Not All Drugs Are the Same

    Feb 1, 2017, 00:00

  • The Probabilistic Efficiency Frontier- A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options

    Feb 1, 2017, 00:00

  • Evaluating Frameworks That Provide Value Measures for Health Care Interventions

    Feb 1, 2017, 00:00

  • Developing a Value Framework- The Need to Reflect the Opportunity Costs of Funding Decisions

    Feb 1, 2017, 00:00

  • Value Assessment Frameworks for HTA Agencies- The Organization of Evidence-Informed Deliberative Processes

    Feb 1, 2017, 00:00

  • The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care- A Government Perspective Analytic Framework

    Feb 1, 2017, 00:00

  • Advancing Value Assessment in the United States- A Multistakeholder Perspective

    Feb 1, 2017, 00:00

  • Using Multicriteria Approaches to Assess the Value of Health Care

    Feb 1, 2017, 00:00

  • Toward a Broader Concept of Value- Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

    Feb 1, 2017, 00:00

  • Table of Contents

    Feb 1, 2017, 00:00

  • Using Cost-Effectiveness Analysis to Address Health Equity Concerns

    Feb 1, 2017, 00:00

  • The Value of Addressing Patient Preferences

    Feb 1, 2017, 00:00

  • Copyright/Subscription

    Feb 1, 2017, 00:00

  • Value Assessment at the Point of Care- Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values

    Feb 1, 2017, 00:00

  • Patient Versus Physician Valuation of Durable Survival Gains- Implications for Value Framework Assessments

    Feb 1, 2017, 00:00

  • The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems

    Feb 1, 2017, 00:00

  • New ISPOR Recommendations - Mapping Methods for Estimation of Health State Utility

    Jan 1, 2017, 00:00

  • Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury- A Systematic Review and Mapping Study

    Jan 1, 2017, 00:00

  • In This Issue

    Jan 1, 2017, 00:00

  • Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service

    Jan 1, 2017, 00:00

  • Reflections on ISPOR’s Clinician-Reported Outcomes Good Measurement Practice Recommendations

    Jan 1, 2017, 00:00

  • The Influence of Genotype Information on Psychiatrists’ Treatment Recommendations- More Experienced Clinicians Know Better What to Ignore

    Jan 1, 2017, 00:00

  • Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery- A Systematic Review

    Jan 1, 2017, 00:00

  • The Challenge of Conditional Reimbursement- Stopping Reimbursement Can Be More Difficult Than Not Starting in the First Place!

    Jan 1, 2017, 00:00

  • Copyright/Subscription

    Jan 1, 2017, 00:00

  • Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures- An ISPOR Good Practices for Outcomes Research Task Force Report

    Jan 1, 2017, 00:00

  • Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies- An Introduction

    Jan 1, 2017, 00:00

  • “What Goes Around Comes Around”- Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

    Jan 1, 2017, 00:00

  • Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice

    Jan 1, 2017, 00:00

  • Decision Making on Medical Innovations in a Changing Health Care Environment- Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

    Jan 1, 2017, 00:00

  • Budget Impact Analysis of Prolonged Half-Life Recombinant FVIII Therapy for Hemophilia in the United States

    Jan 1, 2017, 00:00

  • Variation in Health Technology Assessment and Reimbursement Processes in Europe

    Jan 1, 2017, 00:00

  • Clinician-Reported Outcome Assessments of Treatment Benefit- Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Jan 1, 2017, 00:00

  • Table of Contents

    Jan 1, 2017, 00:00

  • Estimating Preferences for Complex Health Technologies- Lessons Learned and Implications for Personalized Medicine

    Jan 1, 2017, 00:00

  • Incorporating Budget Impact Analysis in the Implementation of Complex Interventions- A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Jan 1, 2017, 00:00

  • A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease

    Jan 1, 2017, 00:00

  • ERRATUM

    Jan 1, 2017, 00:00

  • Priority to End of Life Treatments? Views of the Public in the Netherlands

    Jan 1, 2017, 00:00

  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2017, 00:00

  • Costs and Outcomes of Increasing Access to Bariatric Surgery- Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records

    Jan 1, 2017, 00:00

  • Note to Editors

    Jan 1, 2017, 00:00

  • Results from a Well-Being Survey in the North West of England- Inequalities in EQ-5D–Derived Quality-Adjusted Life Expectancy Are Mainly Driven by Pain and Mental Health

    Jan 1, 2017, 00:00

  • Evaluation of COPD Treatments- A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States

    Jan 1, 2017, 00:00

  • The Burden of Obesity on Diabetes in the United States- Medical Expenditure Panel Survey, 2008 to 2012

    Jan 1, 2017, 00:00

  • Making Choices on the Journey to Universal Health Care Coverage- From Advocacy to Analysis

    Dec 1, 2016, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2016, 00:00

  • EQ-5D Scores for Diabetes-Related Comorbidities

    Dec 1, 2016, 00:00

  • Economic Evaluations of Multicomponent Disease Management Programs with Markov Models- A Systematic Review

    Dec 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States

    Dec 1, 2016, 00:00

  • Health Economics as Rhetoric- The Limited Impact of Health Economics on Funding Decisions in Four European Countries

    Dec 1, 2016, 00:00

  • Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants

    Dec 1, 2016, 00:00

  • Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

    Dec 1, 2016, 00:00

  • Instructions for Authors

    Dec 1, 2016, 00:00

  • How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America

    Dec 1, 2016, 00:00

  • A Differential Item Functioning Analysis of the EQ-5D in Cancer

    Dec 1, 2016, 00:00

  • Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes- A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland

    Dec 1, 2016, 00:00

  • Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer- How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness

    Dec 1, 2016, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight

    Dec 1, 2016, 00:00

  • The International Decision Support Initiative Reference Case for Economic Evaluation- An Aid to Thought

    Dec 1, 2016, 00:00

  • Country-Level Cost-Effectiveness Thresholds- Initial Estimates and the Need for Further Research

    Dec 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia

    Dec 1, 2016, 00:00

  • Editorial Board

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores

    Dec 1, 2016, 00:00

  • Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment

    Dec 1, 2016, 00:00

  • ERRATUM

    Dec 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail- An Empirical Analysis of 5 Years’ Experience

    Dec 1, 2016, 00:00

  • Using Patient-Reported Outcomes for Economic Evaluation- Getting the Timing Right

    Dec 1, 2016, 00:00

  • Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis

    Dec 1, 2016, 00:00

  • Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis- Results of A Belgian Observational Non-Interventional ...

    Nov 1, 2016, 00:00

  • Intravenous Fluids for Children- Cost and Threshold Analysis to Inform the National Institute for Health and Care Excellence (NICE) Clinical Guideline Recommendation

    Nov 1, 2016, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • Barriers To Intravitreal Injection Therapy Adherence In Dme Patients In Australia

    Nov 1, 2016, 00:00

  • Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Polypharmacy and Medication Adherence in Elderly Patients with Diabetes in Pafos General Hospital, Cyprus

    Nov 1, 2016, 00:00

  • Drug Utilisation of Braf Inhibitors for Melanoma in Ireland

    Nov 1, 2016, 00:00

  • Clinical and Economic Benefits of a Community Pharmacy Vaccination Strategy

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Users of Primary Care in Brazil

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Incorporation of A Computerized Temperature Management System In The Treatment of Therapeutic Hypothermia In Greece

    Nov 1, 2016, 00:00

  • Caesarean Section In Xindu County of Chengdu, China- Trend And Its Correlates From 2008 to 2014

    Nov 1, 2016, 00:00

  • The Effect of Reducing Cost-Sharing for Children on Utilization of Inpatient Services- Evidence From Japan

    Nov 1, 2016, 00:00

  • The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015

    Nov 1, 2016, 00:00

  • Cost-Outcome Analysis of Different Intravenous Iron Sucrose Preparations in Hemodialysis Patients

    Nov 1, 2016, 00:00

  • The Current Status And Influential Factors of Insulin Pen Needle Reuse In T2D Patients From China

    Nov 1, 2016, 00:00

  • The Comparisons of Biologics with Methotrexate for Treating Rheumatoid Arthritis Patients in Taiwan- The use of Cost-Utility Analysis and Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Comorbidity of Depression And Type 2 Diabetes- A Retrospective Japanese Claims Database Analysis

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary Hospital

    Nov 1, 2016, 00:00

  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the United States

    Nov 1, 2016, 00:00

  • Programme Budgeting Marginal Analysis for the Real World- The ‘Prudent Pbma’

    Nov 1, 2016, 00:00

  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00

  • Generating Consistent and Reliable Evidence on Survival Estimates for Health Technology Assessment in Oncology and Haematology

    Nov 1, 2016, 00:00

  • The Social Cost of Major Depression

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Pharmacist-Provided Home-Based Medication Review in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Oral Versus Intravenous Iron Treatment in Patients with Inflammatory Bowel Disease and Iron Deficiency and/or Anemia in Germany

    Nov 1, 2016, 00:00

  • Making Pragmatic Trials Work

    Nov 1, 2016, 00:00

  • Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes

    Nov 1, 2016, 00:00

  • Prescribing Behaviour And Drug Use In Pakistan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Children with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ibrutinib For Waldenström Macroglobulinemia In Italy

    Nov 1, 2016, 00:00

  • Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Ankylosing Spondylitis is Associated with Significant Increases in Healthcare Resource Utilization And Costs in A German Real World Setting

    Nov 1, 2016, 00:00

  • Exploring Interest in The Use of A Complementary Therapy Among Individuals With Copd

    Nov 1, 2016, 00:00

  • Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia

    Nov 1, 2016, 00:00

  • Qualitative Research Approaches In Rare Diseases- Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and Caregivers

    Nov 1, 2016, 00:00

  • EQ-5D Utility Value Sets for Sri Lanka- A Case For Economic Evaluations in South Asia

    Nov 1, 2016, 00:00

  • Missed Opportunities in The Netherlands- The Negligence of Non-Statistical Uncertainty in Ced Policy

    Nov 1, 2016, 00:00

  • Pro Instruments for Musculoskeletal Disorders used in Studies Published Since 2005- Which Diseases have had the most Tools Developed?

    Nov 1, 2016, 00:00

  • Adoption of Managed Entry Agreements in Established and Emerging Markets

    Nov 1, 2016, 00:00

  • Psychometric Properties of The Chinese Version of Problem Areas In Diabetes Scale (Sg-Paid-C) Among High-Risk Polypharmacy Patients With Uncontrolled Type 2 Diabetes In Singapore

    Nov 1, 2016, 00:00

  • Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness

    Nov 1, 2016, 00:00

  • Satisfaction Level of Patients, Physicians, and Private Primary Healthcare Center Managers with Chronic Disease Management Program in Indonesia

    Nov 1, 2016, 00:00

  • A Study of Prescription Pattern of Non Steroidal Anii-Inflammatory Drugs in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection Treatment for Gastric Adenoma in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • A Proposed Model for the Study of the Longitudinal Behavior of Prevalence Rates

    Nov 1, 2016, 00:00

  • Self-Care Behavior And Medication Use Of Buddhist Monks With Diabetes Mellitus In Phasi Charoen, Bangkok

    Nov 1, 2016, 00:00

  • Comparison of Health Care Utilization And Cost Depending on The Severity of Asthma in Adults- Analysis of The Korean National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

    Nov 1, 2016, 00:00

  • Adherence To Vancomycin Therapeutic Guidelines At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Overactive Bladder Treatment with Mirabegron in Patients in South Korea

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00

  • Trends in The Utilization, Spending, and Prices For Smoking Cessation and Nicotine Replacement Products In US Medicaid Programs- 1991–2015

    Nov 1, 2016, 00:00

  • Romanian Claw-Back Taxation- From A Financial Solution to A Challenge for Patients Access to Drugs

    Nov 1, 2016, 00:00

  • Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)

    Nov 1, 2016, 00:00

  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00

  • General Practitioners Awareness On Medicines Cost And Financing In Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • The Predirtion of The Brca1/2-Related Ovarian Cancer Morbility In Russia

    Nov 1, 2016, 00:00

  • Non-Invasive Vagus Nerve Stimulation As A Treatment For Headache Patients with Multi-Morbidity- Real World Experience In English Primary Care

    Nov 1, 2016, 00:00

  • Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective

    Nov 1, 2016, 00:00

  • Economic Analyses of Diagnostic Tests for HCC Surveillan A Systematic Review

    Nov 1, 2016, 00:00

  • International Pediatric Hospital Patient Outcomes

    Nov 1, 2016, 00:00

  • Hepatitis B Vaccination in Dialysis Patients. Is it Really Protective?

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Antipsychotic Therapy Results in A Better Treatment Continuity Compared to A One-Monthly or Bi-Weekly Treatment In Schizophrenia

    Nov 1, 2016, 00:00

  • Relevance And Economic Consequences Of Medicine Waste In Vienna- Analysis Of A Household Garbage Sample

    Nov 1, 2016, 00:00

  • Influencing Factors On Knowledge, Attitude And Behaviour Towards Antibiotic Usage Among Adults In Ho Chi Minh City, Viet Nam

    Nov 1, 2016, 00:00

  • Concentration Analysis Of Hungarian Health Care Providers Between 2006-2015

    Nov 1, 2016, 00:00

  • The Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors For Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Economic Burden Of Diseases In Fran Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • The Influence of Glycemic Control in the Quality of Life of Type 2 Diabetes Mellitus Patients in Greece-the Hypo2 Study

    Nov 1, 2016, 00:00

  • Using Geographical Information Systems To Describe Quality Of Life As A Function Of Distance In Cancer Patients

    Nov 1, 2016, 00:00

  • Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective Study

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • Innovative Medical Device Design Significantly Reduces Surgeon Intra-Procedural Stress Levels (Ipsl)

    Nov 1, 2016, 00:00

  • The Stool Antigen Test For Detection of Helicobacter Pylori For Diagnose H.Pylori Infection And Assessment of Eradication Therapy

    Nov 1, 2016, 00:00

  • The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • Can Acute Phase Clinical Outcomes Predict Health-Related Quality of Life After Stroke?

    Nov 1, 2016, 00:00

  • Why Should We Focus on A Structured Model of Secure Digital Exchanges To Incorporate New Documents In Electronic Patient Records?

    Nov 1, 2016, 00:00

  • Impaired Quality Of Life After Chikungunya Virus Infection- A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, Colombia

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • Considerations in Meta-Analytic Network Design- The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)

    Nov 1, 2016, 00:00

  • Understanding the Relationship Between Effectiveness and Outcome Indicators in Health Care

    Nov 1, 2016, 00:00

  • A Systematic Review of Utility Derivation Methods- Time Trade off in Comparison to EQ-5D

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • Severe ulcerative collitis in children and adolescents in poland – it’s time to catch up with Europe. Budget impact analysis (Bia) for biosimilar infliximab

    Nov 1, 2016, 00:00

  • Cost of Type 2 Diabetes in Urban Indian Population

    Nov 1, 2016, 00:00

  • Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes- A Systematic Review

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Improved Influenza Vaccination Coverage in Adults Aged 60 Years and Older in Beijing, China

    Nov 1, 2016, 00:00

  • Closed-System Transfer Device for Preparation of Antineoplastic Drugs in a Malaysian Public Hospital- Is it Truly Cost Saving?

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Challenges For Securing Reimbursement And Access To Cdx In The Eu

    Nov 1, 2016, 00:00

  • Economic Consequences Of The Choices In Injectable Anticoagulants In France

    Nov 1, 2016, 00:00

  • Comparing Coronary Artery Disease Treatment Outcomes – An Example Based on Health-Related Quality of Life Measurements

    Nov 1, 2016, 00:00

  • Perceptions of Thalassemia Patients' on Thalassemia and Its Treatment- A Qualitative Exploration

    Nov 1, 2016, 00:00

  • Using Advanced Modeling To Identify The Factor Structure of The Improved Health Activities Questionnaire

    Nov 1, 2016, 00:00

  • Can Pharmaceutical Care Intervention Improve Lipid Profile in Type 2 Diabetes Patients; A Prospective Intervention Study in a Tertiary Hospital in Nigeria

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Key Aspects in the Modelling of Dengue Transmission- Results from a Focused Literature Review

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of Adult Patients with Advanced Soft Tissue Sarcoma Previously Treated in Spain- Pazopanib vs. Trabectedina

    Nov 1, 2016, 00:00

  • Assessing Statin-Associated Myopathy using Administrative Data from a German Health Insurance Fund- Results of a Pilot Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Do Nutrition Interventions Require a Different Approach to Economic Evaluation?

    Nov 1, 2016, 00:00

  • Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany

    Nov 1, 2016, 00:00

  • Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • The Trend of High Dose Insulin Initiated Among Diabetes Patients in UK

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Systemic Sclerosis- Feasibility and Construct Validity of Eq-5d

    Nov 1, 2016, 00:00

  • Factors Associated with Glycemic Control and Diabetes-Related Costs in Patients with Diabetes in the United Arab Emirates- Results From A Retrospective Large Claims Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Non-Surgical Treatment of Morbid Obesity In Poland

    Nov 1, 2016, 00:00

  • Burden of Disease and Healthcare Costs of Patients Treated with Antiglaucoma Drugs

    Nov 1, 2016, 00:00

  • Cost Per Responder Analysis of Sucrofferric Oxhydroxide Versus Sevelamer Carbonate in Patients on Hemodialysis in Europe

    Nov 1, 2016, 00:00

  • The Situate Detection System - A Cost-Effective Approach to Preventing Retained Surgical Sponges

    Nov 1, 2016, 00:00

  • Fabrication of Anti-Vitiligo Ointment Containing Psoralia Corylifolia- Invitro and Invivo Characterization

    Nov 1, 2016, 00:00

  • Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors- Multilevel Analysis

    Nov 1, 2016, 00:00

  • Integration of HIV Aids Program Intervention into Universal Health Coverage (UHC) - Lesson Learned from Indonesia

    Nov 1, 2016, 00:00

  • Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets

    Nov 1, 2016, 00:00

  • Recommended vs Reimbursed vs Actually used Chemiotherapeutics in Pancreatic Adenocarcinoma in Poland

    Nov 1, 2016, 00:00

  • Budget Impact Model of Secukinumab In The Treatment of Ankylosing Spondylitis (AS) And With Psoriatic Arthritis (PSA) In Italy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treatment of Previously Treated PD-l1 Positive Advanced NSCLC Patients

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Value of Febuxostat For The Treatment of Persistent Hyperuricaemia- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • High-Sensitivity C-Reactive Protein Measurements in Patients with a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Impact Of Us Health Exchanges (Hix) On The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • Comparision Of Perception Towrds Generic Medicines Between Final Year Pharmacy And Medical Students In Southeast Yemen

    Nov 1, 2016, 00:00

  • Asthma in Fran Analysis of 2015 National Health and Wellness Survey Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain

    Nov 1, 2016, 00:00

  • Standardisation and Compatibility Between HTA Networks- what Impacts on Quality?

    Nov 1, 2016, 00:00

  • Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma

    Nov 1, 2016, 00:00

  • The Use of Consensus Techniques to Inform Health Technology Appraisals

    Nov 1, 2016, 00:00

  • A Barriers to and Facilitators of the use of HTA Reports by Policymakers in Kazakhstan

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients with Type 2 Diabetes Mellitus in Taiwan

    Nov 1, 2016, 00:00

  • Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D

    Nov 1, 2016, 00:00

  • HCV- Estimation of the Number of Diagnosed Patients Eligible to New Anti-HCV Therapies in Italy

    Nov 1, 2016, 00:00

  • Cost of Ebola Virus Disease Diagnosis Using Rapid Point-Of-Care Diagnostics in Sierra Leone

    Nov 1, 2016, 00:00

  • Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes

    Nov 1, 2016, 00:00

  • A Review of Studies of Health-Related Quality of Life Performed in Chinese-Speaking Ischemic Heart Disease Patients

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada

    Nov 1, 2016, 00:00

  • Medication Cost Of Acute Myeloid Leukemia- A Descriptive Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Using Stent-Retriever After Intravenous T-PA Compared with Intravenous T-PA Alone in The Treatment of Acute Ischemic Stroke Due to Large Vessel Occlusion in Spain

    Nov 1, 2016, 00:00

  • Measurement Properties of The EQ-5D-5l Compared To The EQ-5D-3L In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sq® Hdm Slit-Tablet For House Dust Mite Respiratory Allergic Disease In Czech Republic

    Nov 1, 2016, 00:00

  • Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Assessing the Broader Economic Consequences of Hpv Prevention in Indonesia Using a Government Perspective Fiscal Analytic Method

    Nov 1, 2016, 00:00

  • Cancer Prevention- Knowledge And Attitudes Among Healthcare Professionals

    Nov 1, 2016, 00:00

  • Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy

    Nov 1, 2016, 00:00

  • Effect of Clinical Pharmacist in Patient Safety-A Prospective Interventional Study

    Nov 1, 2016, 00:00

  • Higher Weight, Higher Burden- Outcomes Of Adults In Japan With Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China

    Nov 1, 2016, 00:00

  • Incidence and Risk Factors of Glucocorticoid-Induced Diabetes Mellitus in Lymphoma Patients Treated with Glucocorticoid-Containing Chemotherapy

    Nov 1, 2016, 00:00

  • Real World Tolerability And Effectiveness of Exenatide Once-Weekly Compared To Basal Insulin Among Elderly Patients with Type 2 Diabetes (T2D)

    Nov 1, 2016, 00:00

  • Comparison Of Biosimilar Guideline And Real Consumption Among Italian Regions

    Nov 1, 2016, 00:00

  • Insights from 6 Years' Managed Entry Agreement Experience in Belgium

    Nov 1, 2016, 00:00

  • A Review of Assessments of The Quality of Pharmacoeconomic Evaluations in China

    Nov 1, 2016, 00:00

  • Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization (HCRU) in Relapsed/Refractory Multiple Myeloma (RRMM)- Comparison of EU and US Cohorts in the Preamble Study

    Nov 1, 2016, 00:00

  • Nine Tests For Assesing Validity Of A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of Hydrophilic Coated Versus Non-Coated Urinary Catheters for Intermittent Use in Japan

    Nov 1, 2016, 00:00

  • Assessment of Knowledge and Perception Regarding Breast Cancer Among Patients Attending Gynecological Department of Tertiary Care Hospital in Quetta Pakistan

    Nov 1, 2016, 00:00

  • Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal Outcomes

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Olaparib Use in Patients Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • Costs and Benefits of Home Food Industry Issuance Program in Indonesia

    Nov 1, 2016, 00:00

  • The Health Economics Analysis of Unqualified Venous Blood Samples In The Chinese Tertiary Referral Hospital

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal

    Nov 1, 2016, 00:00

  • The Cost Of Illness of Ultra-Rare Cryopyrin Associated Periodic Syndromes (CAPS) In Italy- Preliminary Results From The Radicea Project

    Nov 1, 2016, 00:00

  • Willingness To Pay For Primary Dysmenorrhea Health States

    Nov 1, 2016, 00:00

  • Stakeholders Views On The Role Of Hta And Rsas In Pharmaceutical Policy In Greece

    Nov 1, 2016, 00:00

  • Assessment of Awareness and Knowledge of Breast Cancer in Pakistani Females; A Quantitative Study

    Nov 1, 2016, 00:00

  • Costs Associated with Treatment Induced Peripheral Neuropathy in Patients with Multiple Myeloma (MM)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Tiotropium Versus Glycopyrronium In Moderate To Very Severe COPD In France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pazopanib Compared to Sunitinib In the Treatment of Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Cost Analysis Of Comorbities- Evidence From A Hiv+ Patients Cohort

    Nov 1, 2016, 00:00

  • Linear, Flat And Mixed Pricing Structures As Negotiation Quantities Of New Medicinal Products In Context Of Amnog In Germany- A Comparison At Market Launch And Post Price Negotiations

    Nov 1, 2016, 00:00

  • Predictors of First Line Treatment Persistence Among Patients with Metastatic Renal Cell Carcinoma in The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Telemonitoring in Gynaecology and Obstetrics

    Nov 1, 2016, 00:00

  • Drug Utilizaton and Pharmacoeconomic Analysis of Geriatric Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Alcoholism In Italy- An Introductive Analysis of Consumption And Hospitalisation Trends

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis- Treatment Sequencing in Guidelines Compared to Real-World Evidence. A German Claims Data Analysis

    Nov 1, 2016, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • »